Ross W. Paterson

7.0k total citations
75 papers, 2.9k citations indexed

About

Ross W. Paterson is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Ross W. Paterson has authored 75 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Physiology, 32 papers in Psychiatry and Mental health and 18 papers in Neurology. Recurrent topics in Ross W. Paterson's work include Alzheimer's disease research and treatments (39 papers), Dementia and Cognitive Impairment Research (29 papers) and Advanced Neuroimaging Techniques and Applications (7 papers). Ross W. Paterson is often cited by papers focused on Alzheimer's disease research and treatments (39 papers), Dementia and Cognitive Impairment Research (29 papers) and Advanced Neuroimaging Techniques and Applications (7 papers). Ross W. Paterson collaborates with scholars based in United Kingdom, Sweden and United States. Ross W. Paterson's co-authors include Jonathan M. Schott, Henrik Zetterberg, Nick C. Fox, Kaj Blennow, Nadia Magdalinou, Catherine F. Slattery, Amanda Heslegrave, Jason D. Warren, Sebastian J. Crutch and Jamie Toombs and has published in prestigious journals such as Nature Communications, Brain and Neurology.

In The Last Decade

Ross W. Paterson

69 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross W. Paterson United Kingdom	31	1.2k	882	809	667	667	75	2.9k
Brianne M. Bettcher United States	34	1.3k 1.1×	1.4k 1.6×	506 0.6×	702 1.1×	766 1.1×	85	3.7k
Abhay Moghekar United States	37	1.3k 1.1×	1.4k 1.6×	850 1.1×	604 0.9×	600 0.9×	178	4.0k
William T. Hu United States	36	2.1k 1.7×	1.1k 1.2×	1.5k 1.8×	949 1.4×	781 1.2×	113	4.4k
Hakan Gürvıt Türkiye	31	896 0.7×	641 0.7×	917 1.1×	627 0.9×	722 1.1×	171	3.7k
Fanny M. Elahi United States	26	751 0.6×	571 0.6×	365 0.5×	738 1.1×	599 0.9×	67	2.5k
Afina W. Lemstra Netherlands	34	1.4k 1.1×	1.5k 1.7×	1.2k 1.5×	454 0.7×	657 1.0×	122	3.5k
Juan Fortea Spain	42	2.3k 1.9×	1.6k 1.9×	956 1.2×	1.0k 1.6×	789 1.2×	205	5.0k
Annachiara Cagnin Italy	23	1.1k 0.9×	512 0.6×	1.2k 1.4×	749 1.1×	1.3k 2.0×	59	3.5k
Thomas Duning Germany	32	1.0k 0.9×	564 0.6×	474 0.6×	296 0.4×	465 0.7×	101	3.6k
Donna J. Cross United States	25	872 0.7×	421 0.5×	535 0.7×	368 0.6×	292 0.4×	65	2.6k

Countries citing papers authored by Ross W. Paterson

Since Specialization

Citations

This map shows the geographic impact of Ross W. Paterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross W. Paterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross W. Paterson more than expected).

Fields of papers citing papers by Ross W. Paterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross W. Paterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross W. Paterson. The network helps show where Ross W. Paterson may publish in the future.

Co-authorship network of co-authors of Ross W. Paterson

This figure shows the co-authorship network connecting the top 25 collaborators of Ross W. Paterson. A scholar is included among the top collaborators of Ross W. Paterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross W. Paterson. Ross W. Paterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Slattery, Catherine F., Karl Friston, Ross W. Paterson, et al.. (2025). Neural mechanisms of disease pathology and cognition in young-onset Alzheimer's disease variants. Journal of Alzheimer s Disease. 106(2). 653–667.

Zarkali, Angeliki, George E. Thomas, Ross W. Paterson, et al.. (2025). Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space ( DTI ‐ ALPS) , is Linked to Poor Cognitive Outcomes in Parkinson's Disease. Movement Disorders. 40(11). 2367–2380.

Hällqvist, Jenny, Rui Pinto, Wendy Heywood, et al.. (2023). A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer’s Disease Diagnosis Using Targeted Proteomics and Machine Learning. International Journal of Molecular Sciences. 24(18). 13758–13758. 3 indexed citations

Keshavan, Ashvini, Miles Chapman, Melanie Hart, et al.. (2022). CSF biomarkers for dementia. Practical Neurology. 22(4). 285–294. 8 indexed citations

Malone, Ian B., Teresa Poole, Catherine F. Slattery, et al.. (2021). Loss and dispersion of superficial white matter in Alzheimer’s disease: a diffusion MRI study. Brain Communications. 3(4). fcab272–fcab272. 26 indexed citations

Heslegrave, Amanda, Nicholas J. Ashton, Thomas K. Karikari, et al.. (2021). Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. Journal of Internal Medicine. 290(3). 583–601. 60 indexed citations

Norsworthy, Penny J., Andrew G.B. Thompson, Tze How Mok, et al.. (2020). A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis. Nature Communications. 11(1). 3960–3960. 25 indexed citations

Khatun, Ayesha, Konstantin Senkevich, Jörg Hanrieder, et al.. (2020). Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg. Alzheimer s Research & Therapy. 12(1). 20–20. 35 indexed citations

Canas, Liane S., Carole H. Sudre, Enrico De Vita, et al.. (2019). Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process. NeuroImage Clinical. 24. 102051–102051. 4 indexed citations

10.

Arber, Charles, Jamie Toombs, Christopher Lovejoy, et al.. (2019). Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta. Molecular Psychiatry. 25(11). 2919–2931. 98 indexed citations

11.

Dahlén, Rahil, Oskar Hansson, Ross W. Paterson, et al.. (2019). Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease. PubMed. 14. 74–82. 6 indexed citations

12.

Foiani, Martha, Claudia Cicognola, Natalia Ermann, et al.. (2019). Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest. Journal of Neurology Neurosurgery & Psychiatry. 90(7). 740–746. 24 indexed citations

13.

Wellington, Henrietta, Ross W. Paterson, Aida Suárez‐González, et al.. (2018). CSF neurogranin or tau distinguish typical and atypical Alzheimer disease. Annals of Clinical and Translational Neurology. 5(2). 162–171. 28 indexed citations

14.

Yong, Keir, Ian McCarthy, Teresa Poole, et al.. (2018). Navigational cue effects in Alzheimer's disease and posterior cortical atrophy. Annals of Clinical and Translational Neurology. 5(6). 697–709. 18 indexed citations

15.

Paterson, Ross W., Catherine F. Slattery, Teresa Poole, et al.. (2018). Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimer s Research & Therapy. 10(1). 32–32. 105 indexed citations

16.

Paterson, Ross W., et al.. (2016). Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy. Clinical Neurology and Neurosurgery. 144. 64–66. 3 indexed citations

17.

Weston, Philip S.J., Ross W. Paterson, John Dickson, et al.. (2016). Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?. Journal of Alzheimer s Disease. 54(4). 1297–1302. 18 indexed citations

18.

Suárez‐González, Aida, Manja Lehmann, Timothy J. Shakespeare, et al.. (2016). Effect of age at onset on cortical thickness and cognition in posterior cortical atrophy. Neurobiology of Aging. 44. 108–113. 9 indexed citations

19.

Allen, David C., Paul Riordan‐Eva, Ross W. Paterson, & Robert D. M. Hadden. (2013). Subacute peripheral and optic neuropathy syndrome with no evidence of a toxic or nutritional cause. Clinical Neurology and Neurosurgery. 115(8). 1389–1393. 6 indexed citations

20.

Russell, Fraser D., et al.. (1970). Estimation of sodium fusidate levels in human serum, aqueous humour, and vitreous body.. British Journal of Ophthalmology. 54(2). 126–130. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact